Myotonic dystrophy type 2 with focal asymmetric muscle weakness and no electrical myotonia

Muscle and Nerve

Volumn 39, Issue 3, 2009, Pages 383-385

  Milone, Margherita ^a   Batish, Sat D ^b   Daube, Jasper R ^a  

^a MAYO CLINIC   (United States)

^b ATHENA DIAGNOSTICS INC   (United States)

Author keywords

Focal weakness; Myotonia; Myotonic dystrophy type 2

Indexed keywords

CREATINE KINASE;

ADULT; ARTICLE; CASE REPORT; CREATINE KINASE BLOOD LEVEL; ELECTROMYOGRAM; FEMALE; HUMAN; MOTOR UNIT POTENTIAL; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOTONIA; MYOTONIC DYSTROPHY; PRIORITY JOURNAL;

CREATINE KINASE; ELECTROMYOGRAPHY; FEMALE; HUMANS; MIDDLE AGED; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MYOTONIC DYSTROPHY; RNA-BINDING PROTEINS;

EID: 62849111945     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21150     Document Type: Article

References (9)

1. American Association of Electrodiagnostic and Neuromuscular Medicine. AAEM glossary of terms in electrodiagnostic medicine. 2001;24(Suppl 10):2-50.
2. Barkhaus PE, Nandekar SD. Slow myotonic discharges. Muscle Nerve 2006;34:799-800.
3. Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, et al. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 2003;60:657-664.
4. Day JW, Ranum LPW. RNA pathogenesis of the myotonic dystrophies. Neuromuscul Disord 2005;15:5-16.
5. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001;293:864-867.
6. Logigian EL, Ciafaloni E, Quinn LC, Dilek N, Pandya S, et al. Severity, type and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy. Muscle Nerve 2007:35:479-485.
7. Mathieu J, Boivin H, Meunier D, Gaudreault M, Begin P. Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology 2001;56:336-340.
8. Merlini L, Sabatelli P, Columbaro M, Bonifazi E, Pisani V, Massa R, et al. Hyper-CK-emia as the sole manifestation of myotonic dystrophy type 2. Muscle Nerve 2005;31:764-767.
9. Udd B, Meola G, Krahe R, Thornton C, Ranum L, Day G, et al. Report of the 115th ENMC workshop: DM2/PROMM and other myotonic dystrophies. 3rd Workshop, 14-16 February 2003, Naarden, The Netherlands. Neuromuscul Disord 2003; 13:589-596.